Increased Vulnerability to Atrial Fibrillation in Transgenic Mice With Selective Atrial Fibrosis Caused by Overexpression of TGF-β1

Overview of attention for article published in Circulation Research, April 2004

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (71st percentile)
Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

patent: 3 patents

Citations

dimensions_citation: 478 Dimensions

Readers on

mendeley: 200 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

System and method for medical image based cardio-embolic stroke risk prediction

Grant US-11024404-B2

United States of America

Model and method for a transgenic bovidae expressing cardiac fibrosis and associated…

Application US-9999206-B2

United States of America

Myeloperoxidase as a target in atrial fibrillation

Application EP-2366431-A1

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.